Skip to main content
Clinical Trials/NCT03647540
NCT03647540UnknownNot Applicable

The Application of Fluorescence Laparoscopy in the Treatment of Adenocarcinoma of the Esophagogastric Junction

Dong Yang2 sites in 1 country164 target enrollmentStarted: August 30, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
164
Locations
2
Primary Endpoint
the number of the dissected lymph nodes

Study Overview

Brief Summary

The fluorescent laparoscopic technique would be applied to the radical resection of gastric cancer at the junction of esophagus and stomach, and compared with the traditional laparoscopic radical resection of gastric cancer to find a better surgical method for patients

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All cases should be diagnosed as adenocarcinoma of the esophagogastric junctionncer by histology. The tumor is within 1 cm above or 2 cm below the anatomic cardia. The clinical stage is T1-3, Nx, M0 for gastric cancer which can undergo the laparoscopic surgery.
  • Eastern Cooperative Oncology Group (ECOG) scale 0-2
  • Heart, lung, liver, and kidney function can tolerate operation
  • Patients and their families are able to understand and be willing to participate in this clinical study and to sign informed consent.

Exclusion Criteria

  • history of stomach malignant disease
  • recent diagnosis of other malignant tumors (except for papillary carcinoma of the thyroid gland and basal cell carcinoma of the skin)
  • patients with obstruction, perforation, bleeding requiring emergency surgery
  • a history of abdominal surgery (which makes it difficult to perform laparoscopic procedures), severe systemic disease such as diabetes, severe chronic lung disease, cirrhosis, other malignant diseases
  • combined stomach multiple carcinomas
  • with a history of serious mental illness
  • pregnant or lactating women
  • The researchers believe that the patients are unsuitable to participate in the researchers with other cases.

Outcomes

Primary Outcomes

the number of the dissected lymph nodes

Time Frame: in the perioperative period

It includes the total number of the dissected lymph nodes and every group of lymph nodes

Secondary Outcomes

  • 3-year disease-free survival(three years after operation])
  • cases converted to open surgery(in the perioperative period)
  • the incidence of complications(one month after surgery)
  • the blood loss during the operation(in the perioperative period)
  • the operation time(in the perioperative period)
  • Postoperative recovery of intestinal peristalsis(in the perioperative period)
  • The mean postoperative hospital stay(in the perioperative period)

Investigators

Sponsor
Dong Yang
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Dong Yang

Doctor

Jilin University

Study Sites (2)

Loading locations...

Similar Trials